Antibiotic GE2270 A: A novel inhibitor of bacterial protein synthesis. II. Structure elucidation

J. Kettenring, L. Colombo, P. Ferrari, P. Tavecchia, M. Nebuloni, K. Vékey, G. G. Gallo, E. Selva

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

GE2270 A, produced by Planobispora rosea ATCC 53773, inhibits Gram-positive bacteria and anaerobes by acting on the bacterial protein synthesis. The structure has been determined by physico-chemical methods applied to the intact molecule and to the main hydrolysis products. Characterization by UV, IR, NMR (double quantum filter COSY), acid-base ionization, elemental analysis and FAB-MS indicated that GE2270 A is a highly modified peptide having MW 1,289 and formula C56H55N15O10S6, and a weak basic function, and that it belongs to the thiazolyl peptide group of antibiotics. Acid hydrolysis yielded a main product (MW 634), responsible for the chromophoric absorption, and a number of hydrolyzed products of lower MW. 13C NMR inverse techniques and MS studies (EI, positive ion chemical ionization, and collision induced dissociation FAB-MS-MS experiments) on GE2270 A, the chromophoric compound, and the other hydrolysis products led to the complete identification of the various amino acid residues and their sequence. Two out of the six chiral centers have been determined. The structure is thought to originate from modification of a chain of 14 amino acids in a process which creates 6 thiazole rings and one pyridine. The modification process also closes the linear polypeptide to form a cyclic part with an attached side-chain. GE2270 A plausibly has a similar biosynthetic origin to that of other thiazolyl peptide antibiotics such as nosiheptide and micrococcin.

Original languageEnglish
Pages (from-to)702-715
Number of pages14
JournalJournal of Antibiotics
Volume44
Issue number7
Publication statusPublished - 1991

Fingerprint

Protein Synthesis Inhibitors
Bacterial Proteins
Anti-Bacterial Agents
Peptides
Hydrolysis
Amino Acids
Thiazoles
Acids
Gram-Positive Bacteria
Ions
GE 2270 A

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Kettenring, J., Colombo, L., Ferrari, P., Tavecchia, P., Nebuloni, M., Vékey, K., ... Selva, E. (1991). Antibiotic GE2270 A: A novel inhibitor of bacterial protein synthesis. II. Structure elucidation. Journal of Antibiotics, 44(7), 702-715.

Antibiotic GE2270 A : A novel inhibitor of bacterial protein synthesis. II. Structure elucidation. / Kettenring, J.; Colombo, L.; Ferrari, P.; Tavecchia, P.; Nebuloni, M.; Vékey, K.; Gallo, G. G.; Selva, E.

In: Journal of Antibiotics, Vol. 44, No. 7, 1991, p. 702-715.

Research output: Contribution to journalArticle

Kettenring, J, Colombo, L, Ferrari, P, Tavecchia, P, Nebuloni, M, Vékey, K, Gallo, GG & Selva, E 1991, 'Antibiotic GE2270 A: A novel inhibitor of bacterial protein synthesis. II. Structure elucidation', Journal of Antibiotics, vol. 44, no. 7, pp. 702-715.
Kettenring J, Colombo L, Ferrari P, Tavecchia P, Nebuloni M, Vékey K et al. Antibiotic GE2270 A: A novel inhibitor of bacterial protein synthesis. II. Structure elucidation. Journal of Antibiotics. 1991;44(7):702-715.
Kettenring, J. ; Colombo, L. ; Ferrari, P. ; Tavecchia, P. ; Nebuloni, M. ; Vékey, K. ; Gallo, G. G. ; Selva, E. / Antibiotic GE2270 A : A novel inhibitor of bacterial protein synthesis. II. Structure elucidation. In: Journal of Antibiotics. 1991 ; Vol. 44, No. 7. pp. 702-715.
@article{cafc2d3c5bf74236a5e1428ac3483a9f,
title = "Antibiotic GE2270 A: A novel inhibitor of bacterial protein synthesis. II. Structure elucidation",
abstract = "GE2270 A, produced by Planobispora rosea ATCC 53773, inhibits Gram-positive bacteria and anaerobes by acting on the bacterial protein synthesis. The structure has been determined by physico-chemical methods applied to the intact molecule and to the main hydrolysis products. Characterization by UV, IR, NMR (double quantum filter COSY), acid-base ionization, elemental analysis and FAB-MS indicated that GE2270 A is a highly modified peptide having MW 1,289 and formula C56H55N15O10S6, and a weak basic function, and that it belongs to the thiazolyl peptide group of antibiotics. Acid hydrolysis yielded a main product (MW 634), responsible for the chromophoric absorption, and a number of hydrolyzed products of lower MW. 13C NMR inverse techniques and MS studies (EI, positive ion chemical ionization, and collision induced dissociation FAB-MS-MS experiments) on GE2270 A, the chromophoric compound, and the other hydrolysis products led to the complete identification of the various amino acid residues and their sequence. Two out of the six chiral centers have been determined. The structure is thought to originate from modification of a chain of 14 amino acids in a process which creates 6 thiazole rings and one pyridine. The modification process also closes the linear polypeptide to form a cyclic part with an attached side-chain. GE2270 A plausibly has a similar biosynthetic origin to that of other thiazolyl peptide antibiotics such as nosiheptide and micrococcin.",
author = "J. Kettenring and L. Colombo and P. Ferrari and P. Tavecchia and M. Nebuloni and K. V{\'e}key and Gallo, {G. G.} and E. Selva",
year = "1991",
language = "English",
volume = "44",
pages = "702--715",
journal = "Journal of Antibiotics",
issn = "0021-8820",
publisher = "Japan Antibiotics Research Association",
number = "7",

}

TY - JOUR

T1 - Antibiotic GE2270 A

T2 - A novel inhibitor of bacterial protein synthesis. II. Structure elucidation

AU - Kettenring, J.

AU - Colombo, L.

AU - Ferrari, P.

AU - Tavecchia, P.

AU - Nebuloni, M.

AU - Vékey, K.

AU - Gallo, G. G.

AU - Selva, E.

PY - 1991

Y1 - 1991

N2 - GE2270 A, produced by Planobispora rosea ATCC 53773, inhibits Gram-positive bacteria and anaerobes by acting on the bacterial protein synthesis. The structure has been determined by physico-chemical methods applied to the intact molecule and to the main hydrolysis products. Characterization by UV, IR, NMR (double quantum filter COSY), acid-base ionization, elemental analysis and FAB-MS indicated that GE2270 A is a highly modified peptide having MW 1,289 and formula C56H55N15O10S6, and a weak basic function, and that it belongs to the thiazolyl peptide group of antibiotics. Acid hydrolysis yielded a main product (MW 634), responsible for the chromophoric absorption, and a number of hydrolyzed products of lower MW. 13C NMR inverse techniques and MS studies (EI, positive ion chemical ionization, and collision induced dissociation FAB-MS-MS experiments) on GE2270 A, the chromophoric compound, and the other hydrolysis products led to the complete identification of the various amino acid residues and their sequence. Two out of the six chiral centers have been determined. The structure is thought to originate from modification of a chain of 14 amino acids in a process which creates 6 thiazole rings and one pyridine. The modification process also closes the linear polypeptide to form a cyclic part with an attached side-chain. GE2270 A plausibly has a similar biosynthetic origin to that of other thiazolyl peptide antibiotics such as nosiheptide and micrococcin.

AB - GE2270 A, produced by Planobispora rosea ATCC 53773, inhibits Gram-positive bacteria and anaerobes by acting on the bacterial protein synthesis. The structure has been determined by physico-chemical methods applied to the intact molecule and to the main hydrolysis products. Characterization by UV, IR, NMR (double quantum filter COSY), acid-base ionization, elemental analysis and FAB-MS indicated that GE2270 A is a highly modified peptide having MW 1,289 and formula C56H55N15O10S6, and a weak basic function, and that it belongs to the thiazolyl peptide group of antibiotics. Acid hydrolysis yielded a main product (MW 634), responsible for the chromophoric absorption, and a number of hydrolyzed products of lower MW. 13C NMR inverse techniques and MS studies (EI, positive ion chemical ionization, and collision induced dissociation FAB-MS-MS experiments) on GE2270 A, the chromophoric compound, and the other hydrolysis products led to the complete identification of the various amino acid residues and their sequence. Two out of the six chiral centers have been determined. The structure is thought to originate from modification of a chain of 14 amino acids in a process which creates 6 thiazole rings and one pyridine. The modification process also closes the linear polypeptide to form a cyclic part with an attached side-chain. GE2270 A plausibly has a similar biosynthetic origin to that of other thiazolyl peptide antibiotics such as nosiheptide and micrococcin.

UR - http://www.scopus.com/inward/record.url?scp=0025862331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025862331&partnerID=8YFLogxK

M3 - Article

C2 - 1880060

AN - SCOPUS:0025862331

VL - 44

SP - 702

EP - 715

JO - Journal of Antibiotics

JF - Journal of Antibiotics

SN - 0021-8820

IS - 7

ER -